JP2024518680A5 - - Google Patents
Info
- Publication number
- JP2024518680A5 JP2024518680A5 JP2023557097A JP2023557097A JP2024518680A5 JP 2024518680 A5 JP2024518680 A5 JP 2024518680A5 JP 2023557097 A JP2023557097 A JP 2023557097A JP 2023557097 A JP2023557097 A JP 2023557097A JP 2024518680 A5 JP2024518680 A5 JP 2024518680A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- peptide
- tmp
- cys
- linker
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163163265P | 2021-03-19 | 2021-03-19 | |
| US63/163,265 | 2021-03-19 | ||
| PCT/US2022/020818 WO2022197970A2 (en) | 2021-03-19 | 2022-03-17 | T-cell modulatory polypeptides and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024518680A JP2024518680A (ja) | 2024-05-02 |
| JP2024518680A5 true JP2024518680A5 (enExample) | 2025-03-26 |
Family
ID=83322356
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023557097A Pending JP2024518680A (ja) | 2021-03-19 | 2022-03-17 | Ｔ細胞調節ポリペプチド及びその使用方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240067699A1 (enExample) |
| EP (1) | EP4308142A4 (enExample) |
| JP (1) | JP2024518680A (enExample) |
| CN (1) | CN117222421A (enExample) |
| CA (1) | CA3209361A1 (enExample) |
| WO (1) | WO2022197970A2 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019051127A1 (en) | 2017-09-07 | 2019-03-14 | Cue Biopharma, Inc. | MULTIMER MODULATOR POLYPEPTIDE OF LYMPHOCYTE T HAVING CONJUGATION SITES AND METHODS OF USE THEREOF |
| GB202205771D0 (en) * | 2022-04-20 | 2022-06-01 | Replay Holdings Llc | Methods and compositions for cellular therapy |
| CN118221830B (zh) * | 2024-02-06 | 2025-02-18 | 北京臻知医学科技有限责任公司 | T细胞抗原受体及其应用 |
| WO2026125765A1 (en) | 2024-12-13 | 2026-06-18 | Immunoscape Pte. Ltd. | Combination therapy |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6652932B2 (ja) * | 2014-06-18 | 2020-02-26 | アルバート アインシュタイン カレッジ オブ メディシン | ｓｙｎＴａｃポリペプチド及びその使用 |
| CN110325205B (zh) * | 2016-12-22 | 2023-08-15 | 库尔生物制药有限公司 | T细胞调节性多聚体多肽及其使用方法 |
| WO2019005886A1 (en) * | 2017-06-26 | 2019-01-03 | The Broad Institute, Inc. | CRISPR / CAS-CYTIDINE DEAMINASE COMPOSITIONS, SYSTEMS AND METHODS FOR TARGETED EDITING OF NUCLEIC ACIDS |
| EP3678677A4 (en) * | 2017-09-07 | 2021-06-16 | Cue Biopharma, Inc. | ANTIGEN-PRESENTING POLYPEPTIDES AND METHOD FOR THEIR USE |
| WO2019051127A1 (en) * | 2017-09-07 | 2019-03-14 | Cue Biopharma, Inc. | MULTIMER MODULATOR POLYPEPTIDE OF LYMPHOCYTE T HAVING CONJUGATION SITES AND METHODS OF USE THEREOF |
| WO2019139896A1 (en) * | 2018-01-09 | 2019-07-18 | Cue Biopharma, Inc. | Multimeric t-cell modulatory polypeptides and methods of use thereof |
| SG11202100935TA (en) * | 2018-09-28 | 2021-02-25 | Massachusetts Inst Technology | Collagen-localized immunomodulatory molecules and methods thereof |
| TWI856047B (zh) * | 2018-12-19 | 2024-09-21 | 美商信號生物製藥公司 | 多聚體ｔ細胞調節多肽及其使用方法 |
| JP2022536581A (ja) * | 2019-06-19 | 2022-08-18 | キュー バイオファーマ， インコーポレイテッド | 多量体ｔ細胞調節性ポリペプチド及びその使用方法 |
-
2022
- 2022-03-17 CN CN202280027578.9A patent/CN117222421A/zh active Pending
- 2022-03-17 CA CA3209361A patent/CA3209361A1/en active Pending
- 2022-03-17 EP EP22772232.9A patent/EP4308142A4/en active Pending
- 2022-03-17 JP JP2023557097A patent/JP2024518680A/ja active Pending
- 2022-03-17 WO PCT/US2022/020818 patent/WO2022197970A2/en not_active Ceased
-
2023
- 2023-08-16 US US18/234,559 patent/US20240067699A1/en active Pending